Bright Minds Biosciences Inc.
DRUG · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $8 | $1 | $5 | $12 |
| G&A Expenses | $2 | $1 | $2 | $2 |
| SG&A Expenses | $3 | $1 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$1 | $0 | $0 | -$0 |
| Operating Expenses | $10 | $3 | $7 | $15 |
| Operating Income | -$14 | -$3 | -$7 | -$15 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$12 | -$3 | -$7 | -$15 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$3 | -$7 | -$15 |
| % Margin | – | – | – | – |
| EPS | -1.28 | -0.65 | -1.98 | -6.15 |
| % Growth | -96.9% | 67.2% | 67.8% | – |
| EPS Diluted | -1.28 | -0.65 | -1.98 | -6.15 |
| Weighted Avg Shares Out | 7 | 4 | 4 | 2 |
| Weighted Avg Shares Out Dil | 7 | 4 | 4 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $3 | $0 | $0 |
| EBITDA | -$9 | $0 | -$7 | -$15 |
| % Margin | – | – | – | – |